baber/WOPTO huggingface dataset:
Patent DK-0959905-T3 (DK)
Inventor: MOREAU MONIQUE
IPC: A61P37/02
Filed: 1998-01-21
Granted: 2010-04-06
Abstract: The invention relates to a polysaccharide-peptide conjugate wherein the polysaccharide is advantageously immunogenic, which comprises a polysaccharide chain composed of repeat units and a plurality of peptide moieties, each moiety containing a cysteine residue and being covalently attached at random along the polysaccharide chain, through an indirect bond being achieved through either a linker or a spacer-linker moiety provided that the spacer entity of the spacer-linker moiety is linked to the amino, hydroxyl or carboxyl group of the polysaccharide. To this end a useful linker may be, e.g., N-(gamma-maleimidobutyrloxy)succinimide ester. Such a conjugate may typically exhibit a "Rake" configuration. Conjugation processes are also disclosed. Conjugates of the invention are in particular useful in the vaccinal field to elicit a protective long term immune response against a pathogenic microorganism from which the Immunogenic polysaccharide is derived.
Patent DK-0999853-T3 (DK)
Inventor: LAM XANTHE M
IPC: A61P37/04
Filed: 1998-06-12
Granted: 2003-04-22
Abstract: A stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.5 to about 6.0, a surfactant and a polyol is described, along with uses for such a formulation.
Patent DK-1009387-T3 (DK)
Inventor: HUANG HUA-PIN
IPC: A61K9/42
Filed: 1998-07-02
Granted: 2006-08-14
Abstract: A stabilized sustained release oral solid dosage form which includes an effective amount of tramadol or a pharmaceutically acceptable salt thereof dispersed in a matrix of a hydrophobic material comprising a wax-like substance which was melted or softened during the preparation of the matrix, is cured at a temperature from about 35° C. to about 65° C. for a time period from about 4 to about 72 hours, such that the formulation, when subjected to in-vitro dissolution after exposure to accelerated storage conditions of at least one month at 40° C./75% RH, releases an amount of tramadol which does not vary at any given dissolution time point by more than about 20% of the total amount of tramadol released when compared to in-vitro dissolution conducted prior to subjecting the dosage form to the accelerated storage conditions.
Patent DK-1020603-T3 (DK)
Inventor: SCHOLTEN JAN DIPL-ING
IPC: E05F15/614
Filed: 1999-10-12
Granted: 2008-07-28
Abstract: The rotary door drive has an electromagnetic or electrohydraulic drive device that delivers the opening or closing torque required for opening and closing a connected rotary panel, an electronic regulator/controller with at least one memory and at least one microprocessor that causes opening and closing depending on sensor signals via a drive shaft (32). A device between the drive shaft and a rod or actuating arm causes a variation of the opening and/or closing torque over the rotation angle of the connected door panel
Patent DK-1072604-T3 (DK)
Inventor: PLATZEK JOHANNES DR
IPC: A61K33/00
Filed: 1999-09-09
Granted: 2001-06-25
Abstract: Calcium complex of (4R)-4-(bis(carboxymethyl)amino)-6,9-bis(carboxymethyl)-1-(4,4-dipheny lcyclohexyloxy)-1-hydroxy-2-oxa-6,9-diaza-1-phospha-11-undecan oic acid (MS-325) and its salts are new. Calcium complex of ((4R)-4-(bis((carboxy-kappa-O)methyl) amino). kappa.N)-6,9-bis((carboxy-kappa.O)methyl)-1-((4,4-diphenylcyclohexyl)o xy)-1-hydroxy-2-oxa-6,9-diaza-1-phospha-11-undecanoic acid.kappa.N6,.kappa. N9,. kappa.011)1-oxidato (6-))-hexahydrogen (MS-325) and its salts are new. Independent claims are also included for the following: (1) a pharmaceutical composition comprising the calcium complex (Ca-MS-325) and optionally a gadolinium complex of MS-325 (Gd-MS-325); (2) production of a Gd-MS-325 formulation by reacting gadolinium oxide with MS-325 in the presence of a buffer, an (in)organic base and Ca-MS-325; (3) production of a Gd-MS-325 formulation by reacting gadolinium oxide with a MS-325 salt and adding Ca-MS-325.
Patent DK-0995743-T3 (DK)
Inventor: CASARA PATRICK
IPC: C07D221/20
Filed: 1999-10-22
Granted: 2003-07-21
Abstract: Dihydro- and tetrahydro-quinoline derivatives (I) are new. Dihydro- and tetrahydro-quinoline derivatives of formula (I) and their acid or base addition salts are new. R1 = H or a group of formula (i); A = H or -B'NZ1Z2; B' = 1-6C alkylene; Z1, Z2 = H, alkyl, 3-8C cycloalkyl or optionally substituted aryl; or   NZ1Z2 = heterocycloalkyl or heteroaryl (optionally substituted); R2, R3 = alkyl, 3-8C cycloalkyl, heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, optionally substituted arylalkyl, optionally substituted heteroarylalkyl or aminoalkyl (optionally substituted on N with 1 or 2 alkyl, cycloalkyl, aryl or arylalkyl); or R2 + R3 = form with C of quinoline, 3-8C cycloalkyl or heterocycloalkyl (optionally substituted with alkyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl); R40 = alkyl, 2-6C alkenyl, 2-6C alkynyl (all optionally substituted), H, Q or -V'-Q; V' = 1-6C alkylene, 2-6C alkenylene or 2-6C alkynylene; Q = 3-8C cycloalkyl, aryl, heterocycloalkyl, heteroaryl (all optionally substituted); R5, R41 = H; or R5 + R41 = bond; R6-R9 = H, halo, alkyl, 3-8C cycloalkyl or -OW'; W' = aryl, heteroaryl, arylalkyl, heteroarylalkyl (all optionally substituted), H, alkyl, acyl, 3-8C cycloalkyl or heterocycloalkyl; alkyl = 1-6C; aryl = phenyl, naphthyl or biphenyl; heterocycloalkyl = partially unsaturated 4- to 11-membered mono- or bi-cyclic ring containing 1-6 N, S or O; heteroaryl = aromatic or partially aromatic 4- to 11-membered mono- or bi-cyclic ring containing 1-6 N, S or O; substituted aryl, arylalkyl = aryl or arylalkyl substituted with at least one halo, alkyl, 1-6C alkoxy, 1-6C perhaloalkyl, amino (optionally substituted by 1 or 2 alkyl), CN, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl (optionally substituted with 1 or 2 alkyl on N), nitro or OH; substituted alkyl, alkenyl, alkynyl and cycloalkyl = alkyl, alkenyl, alkynyl and cycloalkyl substituted with at least one OH, 1-6C alkoxy, 1-6C alkylthio, amino (optionally substituted with 1 or 2 alkyl), carboxy, nitro, CN, 1-6C alkoxycarbonyl or aminocarbonyl (optionally substituted with 1 or 2 alkyl on N); substituted heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, heteroarylalkyl = heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, heteroarylalkyl substituted with at least one halo, alkyl, 1-6C alkoxy, 1-6C perhaloalkyl, amino (optionally substituted with 1 or 2 alkyl), CN, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl (optionally substituted with 1 or 2 alkyl on N), nitro, OH or oxo; and provided that R6-R9 are not all H and at least one of R6-R9 is -OW', that R2 and R3 are alkyl when R6-R9 are H, alkyl, alkoxy, R41 and R5 form a bond, R40 is other than H or alkyl; when (I) has one OH and R40 is other than H; when (I) has one methoxy and R40 is other than hydroxyalkyl; and (I) is other than 7-methoxy-2,2-diphenyl-1,2-dihydroquinoline. An Independent claim is also included for the preparation of (I).
Patent DK-0977896-T3 (DK)
Inventor: VAN DER LELIE DANIEL
IPC: C12Q1/6897
Filed: 1999-04-12
Granted: 2007-05-21
Abstract: This invention concerns a diagnostic system made of :   a transformed micro-organism capable of an increased reporter activity upon exposure to an environmental insult, said micro-organism having a stress inducible promoter sequence being operatively linked to a reporter encoding nucleic acid sequence encoding a reporter molecule resulting in a signal that can be assayed, and of a transformed micro-organism having a constitutive and non stress inducible promoter sequence being operatively linked to a reporter encoding nucleic acid sequence encoding a reporter molecule resulting in a signal that can be assayed.   <IMAGE>
Patent DK-1094834-T3 (DK)
Inventor: EFENDIC SUAD
IPC: A61K38/31
Filed: 1999-06-08
Granted: 2004-01-05
Abstract: The use of a gastrointestinal peptide hormone, selected from glucagon-like peptide-1 (GLP-1) and its derivatives having anti-secretory effects and smooth muscle relaxatory properties in the gastrointestinal tract, for the manufacture of a pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome, is new. Independent claims are also included for the following: (1) a pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome characterized in that it comprises a combination of at least one member selected from GLP-1 and its derivatives having anti-secretory effects and smooth muscle relaxatory properties in the gastrointestinal tract with one or two more other gastrointestinal peptide hormone(s) and their derivatives having such effects and properties together with additives; and (2) a method for the treatment of functional dyspepsia or irritable bowel syndrome or both in a human patient, comprising administering the composition of (1). ACTIVITY : Anti-inflammatory. MECHANISM OF ACTION : GLP-1 is a gastrointestinal peptide hormone with antisecretory effects and smooth muscle relaxatory properties within the gastrointestinal tract.
Patent DK-1018166-T3 (DK)
Inventor: MOOSHEIMER ULRICH
IPC: B32B7/00
Filed: 1999-06-30
Granted: 2004-11-29
Abstract: A photovoltaic module (1) in the form of a laminate with a solar cell system (2) as the core between encapsulating materials (3, 3'), in which at least one of these materials (3') comprises a sealing layer (4') and a barrier layer (6) consisting of a plastic film or compound foil with an inorganic oxide layer (7) deposited from the vapor phase. An Independent claim is also included for a process for the production of a module (1) by (a) vapor-phase deposition of an oxide layer (7) on a plastic film or compound foil (6), (b) encapsulation of a solar cell system (2) between sealing layers (4, 4'), (c) transferring the module stack to the loading station of a system in which it is kept at a temperature below the softening point of layers (4, 4'), (d) transferring the stack to a vacuum laminator in which it is heated under vacuum to the softening point of (4, 4') and (e) letting in air without cooling, transferring the composite body to a hardening oven and hardening layers (4, 4') to form a laminated module (2) which is then cooled and taken out for further processing.
Patent DK-1094837-T3 (DK)
Inventor: AUDONNET JEAN-CHRISTOPHE FRANCIS
IPC: A61K39/295
Filed: 1999-06-28
Granted: 2010-04-12
Abstract: The invention relates to antigenic preparations and vaccines directed against the porcine multisystemic wasting syndrome (PMWS), comprising at least one porcine circovirus antigen, preferably type II, and at least one porcine parvovirus antigen.
Patent DK-1112097-T3 (DK)
Inventor: SCHOLANDER ELISABETH
IPC: C08B37/00
Filed: 1999-09-08
Granted: 2003-10-20
Abstract: The present invention relates to a process for preparing surface modifications having an improved antithrombogenic activity, whereby the improvement is achieved by treating heparin at a temperature above 40° C. or a pH in the rage of 9-14 or in contact with nucleophilic catalysts before attaching said heparin to the surface to be modified.
Patent DK-1140166-T3 (DK)
Inventor: ALEXANDER JEANNINE
IPC: A61P31/18
Filed: 1999-12-17
Granted: 2007-07-02
Abstract: The present invention relates to immunological adjuvants comprised of the N-formyl methionyl peptide fMLP. fMLP, when used as an adjuvant in accordance with the present invention, provides for an immune response to suboptimal doses of recombinant antigens.
Patent ES-2219216-T3 (ES)
Inventor: HARTMANN SIEGBERT
IPC: A47C23/00
Filed: 2000-02-23
Granted: 2004-12-01
Abstract: The spring element has a foot section which rests on a support surface of a slat of the bed lattice. A support section supports the mattress. The ball-shaped sprung section (2) is rotationally symmetrical about a vertical axis, and consists partly of foamed elasticated rubber. The sprung body is hollow and impermeable to air.
Patent ES-2228412-T3 (ES)
Inventor: ROESSLER ANDREAS
IPC: B23P19/00
Filed: 2000-05-24
Granted: 2005-04-16
Abstract: The invention relates to both a method and a device for feeding fastening elements (1) with a first and a second end, in particular rivets, preferably blind rivets, wherein a fastening element (1) is transported to a junction point (3) at a given orientation by a feed channel (2), and leaves the junction point (3) preferably with the first end in front via a first channel (7) or with the second end in front via a second channel (8).  <IMAGE>
Patent ES-2181629-T3 (ES)
Inventor: CHOQUE JEAN-CHRISTOPHE
IPC: C07H3/02
Filed: 2000-04-21
Granted: 2003-03-01
Abstract: Production of fructose comprises catalytic hydrogenation of a glucosone solution with a solids content of at least 10 wt.% a pressure of at least 20 bar and a temperature of at least 50 degrees C.
Patent ES-2275486-T3 (ES)
Inventor: GUBBINI AMULIO
IPC: A23L35/00
Filed: 2000-11-29
Granted: 2007-06-16
Abstract: A vending apparatus for dispensing pre-cooked pizzas (P) packaged inside corresponding sealed containers (E). The apparatus comprises a casing (1) containing a plurality of operating assemblies (7, 13, 17, 25, 31, 37) for picking up a pizza (P) from a refrigerated storage unit (5) and transferring it, after taking it out of its container (E), to an electric heating oven (30), and then to a delivery mouth (34), in a corresponding disposable tray (T). <IMAGE>
Patent ES-2253201-T3 (ES)
Inventor: YONEDA TOYOAKI
IPC: A61K47/26
Filed: 2000-01-11
Granted: 2006-06-01
Abstract: One pack liquid perfusion preparation comprises an aqueous solution of at least one D-3-hydroxybutyric acid or its salts, a hydrogencarbonate and calcium glycerophosphate. ACTIVITY : Ophthalmological. In tests in which a needle was inserted into the cornea of Dutch rabbits administration of a perfusion solution containing 1.0 mM calcium glycerophosphate, 25.0 mM sodium hydrogencarbonate and 20.0 mM sodium D-3-hydroxybutyrate at 10 ml/min for 120 minutes significantly (p is less than 0.05) reduced eye tissue damage. MECHANISM OF ACTION : None given.
Patent ES-2241578-T3 (ES)
Inventor: DOAT ARNAUD
IPC: A46B5/00
Filed: 2000-02-16
Granted: 2005-11-01
Abstract: The toothbrush, made from a hard but lightweight plastic, consists of a head (6) with bristles (9) and a handle (17). Between the head and handle it has a circular collar (16), perpendicular or inclined relative to the lengthwise axis of the brush, and the handle has at least one flat surface (18), so that when the brush is laid on a horizontal support the bristles are raised above the surface of the support.
Patent ES-2330300-T3 (ES)
Inventor: SOMA GENICHIRO
IPC: A61K35/74
Filed: 2000-03-23
Granted: 2009-12-09
Abstract: A feedstuff additive for crustaceans and fishes, characterized in that it is prepared from gram-negative bacteria, that it has a molecular weight of 5000 +/- 2000 as measured by SDS-PAGE method using a protein marker, that it is substantially free of high molecular weight lipopolysaccharide, that it contains a low molecular weight lipopolysaccharide as an effective component and that it is capable of activating immunity and preventing infection in crustaceans or fishes ; and a feed for crustaceans and fishes comprising the above feedstuff additive.
Patent ES-2308973-T3 (ES)
Title: Configuracion de antenas de doble banda.
Inventor: LINDMARK BJORN
IPC: H01Q21/30
Filed: 2000-03-10
Granted: 2008-12-16
Abstract: Una configuración de antenas para recibir y transmitir señales electromagnéticas en al menos dos bandas de frecuencias separadas entre sí, incluyendo una primera banda de frecuencias que tiene una primera frecuencia central (f1) y una segunda banda de frecuencias, que tiene una segunda frecuencia central (f2), que comprende: - un primer conjunto de elementos de antena (A1; A11-A14) que son operativos en la mencionada primera banda de frecuencias (f1), - un segundo conjunto de elementos de antena (A2; A21-A28) que son operativos en la mencionada segunda banda de frecuencias (f2), - una red de alimentación dispuesta para alimentar las señales, en las mencionadas primera y segunda bandas de frecuencias, hacia el mencionado primer y segundo conjuntos de los elementos de antena, respectivamente, caracterizada porque: - el primer y segundo conjuntos de elementos de antena (A1; A11-A14 y A2; A21-A28) están dispuestos a lo largo de una rila lineal común que define una primera dirección, - los mencionados elementos de antena (A1; A11-A14) en el mencionado primer conjunto de elementos de antena están configurados geométricamente, de forma que el mencionado primer conjunto tiene una primera longitud (D1; D10) en una mencionada primera dirección, - los mencionados elementos de antena (A2; A21-A28) en el mencionado segundo conjunto de elementos de antena, que están configurados geométricamente, de forma que el mencionado segundo conjunto tiene una segunda longitud (D2; D20), en la mencionada primera dirección, y - las mencionadas primera y segunda longitudes (D1, D2; D10, D20) son substancialmente inversamente proporcionales a las respectivas y mencionadas primera y segunda frecuencias centrales (f1, f2), - por lo que el ancho del haz del lóbulo de radiación (L1) transmitido desde el primer conjunto de elementos de antena (A1; A11-A14) es substancialmente el mismo que el ancho del haz del lóbulo de radiación (L2) transmitido desde el segundo conjunto de elementos de antena (A2; A21-A28).
Patent ES-2244420-T3 (ES)
Inventor: CHEETHAM SHARON CRAWFORD
IPC: A61K31/13
Filed: 2000-03-17
Granted: 2005-12-16
Abstract: A compound of formula Ior a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl, including individual enantiomers or racemates thereof, (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride optionally in the form of its monohydrate) is used for treating sleeping disorders including sleep apnoea and snoring.
Patent ES-2213009-T3 (ES)
Inventor: KAYYEM JON FAIZ
IPC: C12Q1/6825
Filed: 2000-04-21
Granted: 2004-08-16
Abstract: Figure (1) depicts some preferred embodiments of the invention. Figure (1A) depicts a solid support (5) that has a sample inlet port (10), a first microchannel (15), a storage module (25) (for example, for assay reagents) with a second microchannel (20). The second microchannel (20B), may be in fluid contact directly with the detection module (30) comprising a detection electrode (35), or (20A), a self-assembled monolayer and a binding ligand. Figure (1B) depicts a sample handling well (40) and a second storage well (25A) with a microchannel (20) to the sample handling well (40). For example, the sample handling well (40) could be a cell lysis chamber and the storage well (25A) could contain lysis reagents. Figure (1C) depicts a sample handling well (40) that is a cell capture or enrichment chamber, with an additional reagent storage (25B) for elution buffer. Figure (1D) depicts the addition of a reaction module (45), with a storage module (25C), for example for storage of amplification reagents. Optional waste module (26) is connected to the reaction module (45) via a microchannel (27). All of these embodiments may additionally comprise valves, waste wells, and pumps, including additional electrodes. <IMAGE> <IMAGE> <IMAGE> <IMAGE>
Patent ES-2246853-T3 (ES)
Inventor: DANEK CHRISTOPHER JAMES
IPC: A61F2/86
Filed: 2000-04-21
Granted: 2006-03-01
Abstract: This relates to treating an asthmatic lung and more particularly, relates to advancing a treatment device into the lung and treating the lung with the device. This also includes additional steps of treating the airway wall, applying energy or heat to the airway wall in an asthmatic lung.
Patent ES-2213062-T3 (ES)
Title: Dispositivo anti-efraccion de batiente.
Inventor: GELIN MICHEL
IPC: E05B45/06
Filed: 2000-11-29
Granted: 2004-08-16
Abstract: Dispositivo anti-efracción que puede ser fijado en una superficie de una pared de recepción situada en, al menos, una parte de la periferia de un batiente, tal como una puerta o una contraventana, o junto a él, caracterizado porque comprende un elemento tubular (7, 25) alargado que presenta una pared (8) de apoyo que se apoya en dicha superficie (5) de recepción, al menos un órgano (12, 12a) de fijación, que atraviesa un paso dispuesto en dicha pared (8) de apoyo del elemento alargado y que se fija en dicha pared (2) de recepción, al menos un órgano (15) elástico de recuperación, colocado en dicho elemento alargado e interpuesto entre dicho órgano de fijación y dicha pared de apoyo de dicho elemento alargado, así como, al menos, un sensor (20) de desplazamiento, instalado en dicho elemento alargado y que coopera con dicha pared de recepción, de tal modo que, cuando dicho elemento alargado sea forzado contra dicho órgano elástico y se separe de dicha pared de recepción, dicho sensor de desplazamiento sea capaz de emitir una señal eléctrica.
Patent ES-2278663-T3 (ES)
Inventor: FERRARA NAPOLEONE
IPC: A61K38/00
Filed: 1992-10-28
Granted: 2007-08-16
Abstract: (A) A compsn. is claimed comprising a human vascular endothelial growth factor (hVEGF) antagonist, provided however that the antagonist is not the flt or flk-1 or KOR receptor or a neutralising anti-hVEGF antibody. Also claimed are: (B) a monoclonal antibody (MAb) amino acid sequence capable of specifically binding to a HVEGF receptor (hVEGFr) or a hVEGF-hVEGFr; (C) a polypeptide comprising an amino acid sequence comprising a bVEGFr and an immunoglobulin chain; (D) a method of treatment of a tumour in a mammal comprising administering a HVEGF antagonist to reduce the size of the tumour.
Patent ES-2280304-T3 (ES)
Title: Aleacion de acero, soportes y piezas de soportes para herramientas de moldeo de plastico y piezas en bruto endurecidas por templado para soportes y piezas de soportes.
Inventor: SANDBERG ODD
IPC: C22C38/46
Filed: 2001-11-22
Granted: 2007-09-16
Abstract: Una aleación de acero que tiene una composición química que contiene en % en peso: 0, 06 a 0, 15 de C 0, 16 < C + N < 0, 26 0, 1 a 1, 0 de Si 0, 1 a 2, 0 de Mn 12, 5 a 14, 5 de Cr 0, 8 a 2, 5 de Ni 0, 1 a 1, 5 de Mo opcionalmente vanadio hasta un máximo de 0, 7 de V opcionalmente uno o más de los elementos S, C y O para mejorar la capacidad de mecanización del acero, en cantidades de hasta 0, 25 de S como máximo, 0, 01 (100 ppm) de Ca como máximo, 0, 01 (100 ppm) de O como máximo, el resto de hierro e impurezas inevitables.
Patent ES-2240426-T3 (ES)
Title: Articulacion esferica con prueba de desgaste.
Inventor: HEIDEMANN MANFRED
IPC: F16C11/06
Filed: 2001-02-27
Granted: 2005-10-16
Abstract: Articulación esférica, preferentemente, para suspensiones de chasis o direcciones de automóviles con una caja de articulación y un gorrón de articulación que está alojado de forma giratoria y orientable en un semicojinete de una o varias piezas mediante una superficie de cojinete de forma esférica, en la que el semicojinete por su parte está fijado en la caja de articulación, y en la que la caja de articulación o el gorrón de articulación están fijados aislados eléctricamente respecto a la suspensión de chasis o la dirección, caracterizada porque en estado montado en el vehículo, la caja de articulación (1) y el gorrón de articulación (2) están unidos entre sí mediante un contacto eléctrico (12, 14) a un dispositivo de medición de potencial (13) y la superficie de cojinete de forma esférica del gorrón de articulación (2) y su correspondiente superficie de contracojinete están configurados de forma aislada eléctricamente entre sí en la caja de articulación (1).
Patent ES-2183754-T3 (ES)
Inventor: FELGEN FERNAND
IPC: B23D25/12
Filed: 2001-02-16
Granted: 2004-11-01
Abstract: A device for producing metal fibers from a metal wire comprises a forming assembly (14) and a cutting assembly (16), said cutting assembly (16) being arranged downstream of said forming assembly (14) in the direction of production, said forming assembly (16) being driven by driving means (58). Said cutting assembly (16) is driven by said driving means (58) and said forming assembly (16) and said cutting assembly (14) are mechanically synchronized.